Pioneering Gene Writing to Treat Diseases at Their Source

Time: 4:10 pm
day: Day One


  • RNA Gene Writing™ platform demonstrates clinically relevant levels of in vivo rewriting in the genome of liver cells of non-human primates following a single administration
  • RNA Gene Writing™ platform generates tumor-clearing CAR T cells by all-RNA delivery
  • Proprietary LNP platform demonstrates the ability to deliver to hematopoietic stem cells and T cells in vivo in both mice and non-human primates